Cysteine Proteinase Inhibitors
"Cysteine Proteinase Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Exogenous and endogenous compounds which inhibit CYSTEINE ENDOPEPTIDASES.
Descriptor ID |
D015853
|
MeSH Number(s) |
D27.505.519.389.745.325
|
Concept/Terms |
Cysteine Proteinase Inhibitors- Cysteine Proteinase Inhibitors
- Inhibitors, Cysteine Proteinase
- Proteinase Inhibitors, Cysteine
- Cysteine Protease Inhibitors
- Inhibitors, Cysteine Protease
- Protease Inhibitors, Cysteine
- Cysteine Proteinase Antagonists
- Antagonists, Cysteine Proteinase
- Proteinase Antagonists, Cysteine
alpha-Cysteine Protease Inhibitors- alpha-Cysteine Protease Inhibitors
- Inhibitors, alpha-Cysteine Protease
- Protease Inhibitors, alpha-Cysteine
- alpha Cysteine Protease Inhibitors
|
Below are MeSH descriptors whose meaning is more general than "Cysteine Proteinase Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Cysteine Proteinase Inhibitors".
This graph shows the total number of publications written about "Cysteine Proteinase Inhibitors" by people in this website by year, and whether "Cysteine Proteinase Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 3 | 1 | 4 |
1998 | 2 | 2 | 4 |
1999 | 2 | 2 | 4 |
2000 | 2 | 1 | 3 |
2003 | 0 | 1 | 1 |
2004 | 0 | 1 | 1 |
2005 | 0 | 1 | 1 |
2006 | 1 | 0 | 1 |
2007 | 2 | 2 | 4 |
2008 | 2 | 0 | 2 |
2009 | 1 | 2 | 3 |
2010 | 2 | 1 | 3 |
2011 | 3 | 3 | 6 |
2012 | 1 | 3 | 4 |
2014 | 3 | 0 | 3 |
2016 | 1 | 1 | 2 |
2018 | 1 | 0 | 1 |
2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cysteine Proteinase Inhibitors" by people in Profiles.
-
Proteasome inhibition suppress microgravity elevated RANK signaling during osteoclast differentiation. Cytokine. 2020 01; 125:154821.
-
Distinct Cytokine and Chemokine Expression in Plasma and Calpeptin-Treated PBMCs of a Relapsing-Remitting Multiple Sclerosis Patient: A Case Report. Neurochem Res. 2018 Dec; 43(12):2224-2231.
-
Neuron-microglia interaction induced bi-directional cytotoxicity associated with calpain activation. J Neurochem. 2016 11; 139(3):440-455.
-
Chronic cathepsin inhibition by E-64 in Dahl salt-sensitive rats. Physiol Rep. 2016 09; 4(17).
-
Effects of a novel orally administered calpain inhibitor SNJ-1945 on immunomodulation and neurodegeneration in a murine model of multiple sclerosis. J Neurochem. 2014 Jul; 130(2):268-79.
-
The cysteine protease cathepsin B is a key drug target and cysteine protease inhibitors are potential therapeutics for traumatic brain injury. J Neurotrauma. 2014 Mar 01; 31(5):515-29.
-
Brain pyroglutamate amyloid-? is produced by cathepsin B and is reduced by the cysteine protease inhibitor E64d, representing a potential Alzheimer's disease therapeutic. J Alzheimers Dis. 2014; 41(1):129-49.
-
Therapeutic effect of MG-132 on diabetic cardiomyopathy is associated with its suppression of proteasomal activities: roles of Nrf2 and NF-?B. Am J Physiol Heart Circ Physiol. 2013 Feb 15; 304(4):H567-78.
-
Lysosomal instability and cathepsin B release during acetaminophen hepatotoxicity. Basic Clin Pharmacol Toxicol. 2012 Dec; 111(6):417-25.
-
The isoprenoid perillyl alcohol inhibits telomerase activity in prostate cancer cells. Biochimie. 2012 Dec; 94(12):2639-48.